KROS Cash & Short-Term Investments

Keros Therapeutics Inc · Cash & Short-Term Investments

KROS logo

KROS Cash & Short-Term Investments

Latest reported$287.42M
KROS FY Cash & Short-Term Investments ($23.26M → $287.42M)
High-resolution chart · PNG

KROS cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Cash & Short-Term Investments — Annual fiscal periods (USD)
Period endingCash & Short-Term Investments (USD)
287,415,000
559,931,000
331,147,000
279,048,000
230,042,000
265,876,000
7,020,000
23,259,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.